Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Chapman

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
The Journal of Biological Chemistry|February 5, 1988
A tissue-type plasminogen activator mutant with prolonged clearance in vivo. Effect of removal of the growth factor domainM J Browne, J E Carey, C G Chapman, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1996
Agonist potency at the cloned human beta-3 adrenoceptor depends on receptor expression level and nature of assayS Wilson, J K Chambers, J E Park, et al.
Circulation|August 1, 1992
A recombinant, chimeric enzyme with a novel mechanism of action leading to greater potency and selectivity than tissue-type plasminogen activatorJ H Robinson, M J Browne, J E Carey, et al.
Brain Research. Molecular Brain Research|October 24, 2000
Cloning, localisation and functional expression of a novel human, cerebellum specific, two pore domain potassium channelC G Chapman, H J Meadows, R J Godden, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
The Journal of Biological Chemistry|February 5, 1988
A tissue-type plasminogen activator mutant with prolonged clearance in vivo. Effect of removal of the growth factor domainM J Browne, J E Carey, C G Chapman, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1996
Agonist potency at the cloned human beta-3 adrenoceptor depends on receptor expression level and nature of assayS Wilson, J K Chambers, J E Park, et al.
Circulation|August 1, 1992
A recombinant, chimeric enzyme with a novel mechanism of action leading to greater potency and selectivity than tissue-type plasminogen activatorJ H Robinson, M J Browne, J E Carey, et al.
Brain Research. Molecular Brain Research|October 24, 2000
Cloning, localisation and functional expression of a novel human, cerebellum specific, two pore domain potassium channelC G Chapman, H J Meadows, R J Godden, et al.
Pageof 3